Anomalous Left Coronary Artery from Pulmonary Artery: An Important Cause of Ischemic Mitral Regurgitation in Children

Muhammad Kamran Younis Memon1, Muneer Amanullah2, Mehnaz Atiq3

  • 1Pediatrics and Child Health, Liaquat National Hospital and Medical College, Karachi, USA.

Cureus
|June 28, 2019
PubMed

Insights

Anomalous left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital heart defect. Unexplained mitral regurgitation in survivors suggests ALCAPA, with surgical repair significantly improving heart function.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Pediatric Cardiology

Background:

  • Anomalous left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital anomaly.
  • Infantile presentation typically involves congestive heart failure or inconsolable crying due to myocardial ischemia.
  • Late survivors often present with mitral regurgitation from papillary muscle ischemia.

Purpose of the Study:

  • To highlight unexplained mitral regurgitation as a diagnostic clue for ALCAPA.
  • To evaluate the outcomes of surgical reimplantation in ALCAPA patients.

Main Methods:

  • Retrospective review of six ALCAPA patients operated between June 2017 and May 2018.
  • Analysis of clinical presentation, electrocardiography, echocardiography, and angiographic findings.
  • Assessment of surgical outcomes, including ventricular function and mitral regurgitation.

Main Results:

  • All six patients presented with mitral regurgitation; two had signs of cardiac failure.
  • The mean left ventricular ejection fraction was 52 ± 12%, with all patients showing mitral regurgitation.
  • Surgical reimplantation was successful, leading to improved left ventricular function and reduced mitral regurgitation post-operatively.

Conclusions:

  • ALCAPA diagnosis can be challenging, especially in late presenters.
  • Persistent, unexplained mitral regurgitation should prompt suspicion for ALCAPA.
  • Surgical intervention for ALCAPA yields excellent outcomes, improving both cardiac function and mitral regurgitation.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
449
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
297
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
314